A global study finds that gaps in information and support are linked to poorer quality of life for people with chronic lymphocytic leukaemia. 

A global study finds that gaps in information and support are linked to poorer quality of life for people with chronic lymphocytic leukaemia. 

A global study of people living with chronic lymphocytic leukaemia (CLL) has identified gaps in patients’ understanding of their condition, with findings showing that knowledge about infection risk and disease monitoring is linked to quality of life. The study, coordinated by international charity Picker and published in Frontiers in Hematology, analysed responses […]

Read More
Researchers unveil a breakthrough targeted therapy for a rare blood cancer

Researchers unveil a breakthrough targeted therapy for a rare blood cancer

Researchers have developed a targeted therapy offering new hope for patients living with a rare form of blood cancer. By focusing on specific cancer cells while sparing healthy ones, this innovation represents a significant step toward more effective and less toxic treatment options. “People with myelofibrosis are often treated with […]

Read More
Urgent Appeal: Young People Needed to Save Lives

Urgent Appeal: Young People Needed to Save Lives

Appeal for more young people to step forward as stem cell donors to save lives An urgent appeal was made in the UK Parliament for more young people to join the stem cell donor register because for many patients with blood cancers or rare blood disorders, finding a match is […]

Read More
Hope in the fight against blood cancer

Hope in the fight against blood cancer

Hope in the fight against blood cancer Johnson & Johnson has received FDA (food and drug administration federal agency) approval for a new treatment option for adults newly diagnosed with multiple myeloma who are not eligible for an autologous stem cell transplant in the United State. The treatment, Darzalex Faspro, […]

Read More
Clinical breakthrough: Manchester Royal Infirmary delivers UK first NHS treatment to a patient with an aggressive blood cancer

Clinical breakthrough: Manchester Royal Infirmary delivers UK first NHS treatment to a patient with an aggressive blood cancer

A 28-year-old patient with acute lymphoblastic leukaemia, has become the first patient in the UK to be treated on the NHS with an innovative personalised therapy at Manchester Royal Infirmary.  https://www.youtube.com/watch?v=dvOmDOzsHN0&t=19s The CAR-T treatment, known as obe-cel, has been developed, researched, and manufactured in the UK and specialists at Manchester […]

Read More
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.